A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.
Table 3. Notification rates of diseases by state or territory, 1 January to 31 March 2003. (Rate per 100,000 population)
Disease |
State or Territory | Australia | |||||||
|---|---|---|---|---|---|---|---|---|---|
| ACT | NSW | NT | Qld | SA | Tas | Vic | WA | ||
Bloodborne diseases |
|||||||||
| Hepatitis B (incident) | 0.0 |
1.1 |
10.1 |
1.1 |
0.3 |
1.7 |
2.9 |
2.5 |
1.7 |
| Hepatitis B (unspecified) | 19.9 |
42.1 |
NN |
19.0 |
10.8 |
16.1 |
35.6 |
20.7 |
30.5 |
| Hepatitis C (incident) | 2.5 |
0.7 |
NN |
NN |
3.4 |
0.8 |
1.1 |
8.5 |
2.1 |
| Hepatitis C (unspecified) | 74.5 |
95.3 |
87.0 |
71.2 |
36.3 |
93.8 |
70.9 |
66.4 |
76.9 |
| Hepatitis D | 0.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.0 |
0.2 |
0.0 |
0.1 |
| Hepatitis (NEC) | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Gastrointestinal diseases |
|||||||||
| Botulism | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Campylobacterosis2 | 129.1 |
NN |
190.2 |
127.5 |
223.3 |
136.0 |
128.6 |
106.1 |
137.2 |
| Cryptosporidiosis | 5.0 |
3.5 |
109.3 |
5.4 |
5.3 |
2.5 |
4.5 |
53.8 |
10.2 |
| Haemolytic uraemic syndrome | 0.0 |
0.1 |
2.0 |
0.0 |
0.0 |
0.0 |
0.2 |
0.0 |
0.1 |
| Hepatitis A | 2.5 |
2.3 |
36.4 |
2.1 |
0.5 |
1.7 |
2.0 |
1.7 |
2.3 |
| Hepatitis E | 0.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Listeriosis | 0.0 |
0.4 |
0.0 |
0.4 |
0.0 |
0.8 |
0.7 |
0.2 |
0.4 |
| Salmonellosis | 38.5 |
44.8 |
214.5 |
91.3 |
38.1 |
53.2 |
47.0 |
47.8 |
55.7 |
| Shigellosis | 3.7 |
1.2 |
93.1 |
2.6 |
2.9 |
0.8 |
1.5 |
5.4 |
3.0 |
| SLTEC,VTEC3 | 0.0 |
0.0 |
0.0 |
0.2 |
3.9 |
0.0 |
0.2 |
0.0 |
0.4 |
| Typhoid | 0.0 |
0.2 |
0.0 |
0.0 |
0.0 |
0.8 |
0.9 |
0.6 |
0.4 |
Quarantinable diseases |
|||||||||
| Cholera | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Plague | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Rabies | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Viral haemorrhagic fever | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Yellow fever | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Sexually transmissible diseases |
|||||||||
| Chlamydial infection | 131.6 |
105.7 |
795.1 |
202.7 |
123.5 |
116.6 |
126.0 |
192.9 |
146.6 |
| Donovanosis | 0.0 |
0.0 |
8.1 |
0.3 |
0.0 |
0.0 |
0.0 |
0.0 |
0.1 |
| Gonococcal infection4 | 8.7 |
18.0 |
661.6 |
28.0 |
19.7 |
9.3 |
25.0 |
81.1 |
34.0 |
| Syphilis5 | 1.2 |
13.4 |
149.7 |
3.9 |
1.6 |
5.1 |
7.5 |
5.6 |
9.4 |
Vaccine preventable diseases |
|||||||||
| Diphtheria | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Haemophilus influenzae type b | 0.0 |
0.1 |
0.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Laboratory-confirmed influenza | 3.7 |
2.9 |
2.0 |
1.8 |
0.8 |
0.0 |
0.3 |
2.1 |
1.8 |
| Measles | 0.0 |
0.0 |
0.0 |
0.4 |
0.3 |
0.0 |
1.3 |
0.0 |
0.4 |
| Mumps | 0.0 |
0.7 |
0.0 |
0.2 |
0.5 |
0.0 |
0.0 |
0.6 |
0.4 |
| Pertussis | 14.9 |
22.8 |
8.1 |
24.2 |
11.3 |
17.7 |
10.5 |
10.1 |
17.5 |
| Pneumococcal disease - invasive | 9.9 |
5.2 |
22.3 |
4.7 |
8.1 |
5.1 |
6.0 |
5.4 |
5.8 |
| Rubella6 | 0.0 |
0.7 |
0.0 |
2.5 |
0.0 |
0.0 |
0.2 |
0.4 |
0.8 |
| Tetanus | 0.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Vectorborne diseases |
|||||||||
| Arbovirus infection NEC | 0.0 |
0.4 |
0.0 |
1.9 |
0.0 |
0.0 |
0.3 |
0.0 |
0.6 |
| Barmah Forest virus infection | 1.2 |
4.3 |
18.2 |
19.8 |
0.3 |
0.0 |
0.3 |
1.2 |
5.6 |
| Dengue | 2.5 |
1.7 |
8.1 |
30.8 |
0.5 |
0.0 |
0.2 |
2.1 |
6.8 |
| Japanese encephalitis | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Kunjin virus infection | - |
0.0 |
0.0 |
0.4 |
0.0 |
0.0 |
0.0 |
0.0 |
0.1 |
| Malaria | 5.0 |
2.7 |
28.3 |
8.4 |
0.8 |
1.7 |
1.6 |
1.9 |
3.5 |
| Murray Valley encephalitis | - |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Ross River virus infection | 0.0 |
3.2 |
204.4 |
38.6 |
2.1 |
1.7 |
0.2 |
8.9 |
11.6 |
Zoonoses |
|||||||||
| Anthrax | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Australian bat lyssavirus | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Brucellosis | 0.0 |
0.1 |
0.0 |
0.3 |
0.0 |
0.0 |
0.0 |
0.0 |
0.1 |
| Leptospirosis | 0.0 |
1.1 |
0.0 |
2.9 |
0.0 |
0.0 |
0.0 |
0.0 |
0.9 |
| Other lyssavirus | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Ornithosis | 0.0 |
0.4 |
0.0 |
0.1 |
0.0 |
0.0 |
1.3 |
0.0 |
0.5 |
| Q fever | 1.2 |
6.8 |
2.0 |
7.7 |
0.5 |
0.0 |
0.5 |
0.8 |
4.0 |
Other bacterial infections |
|||||||||
| Legionellosis | 0.0 |
1.1 |
4.0 |
0.8 |
2.6 |
0.8 |
2.5 |
2.9 |
1.7 |
| Leprosy | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.1 |
0.0 |
0.0 |
| Invasive meningococcal infection | 1.2 |
1.7 |
2.0 |
1.7 |
1.6 |
1.7 |
2.0 |
1.7 |
1.7 |
| Tuberculosis | 7.4 |
4.0 |
10.1 |
0.9 |
2.6 |
0.8 |
4.9 |
2.3 |
3.4 |
1. Rates are subject to retrospective revision.
2. Not reported for New South Wales because it is only notifiable as 'foodborne disease' or 'gastroenteritis in an institution'.
3. Infections with Shiga-like toxin (verotoxin) producing E. coli (SLTEC/VTEC).
4. Northern Territory, Queensland, South Australia , Victoria and Western Australia: includes gonococcal neonatal ophthalmia.
5. Includes congenital syphilis.
6. Includes congenital rubella.
NN Not notifiable.
NEC Not elsewhere classified.
- Elsewhere classified.
This article was published in Communicable Diseases Intelligence Volume 27, No 2, June 2003.
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance
This issue - Vol 27, No 2, June 2003
Communicable Diseases Intelligence